[go: up one dir, main page]

SE445643B - Cykliska acetaler, forfarande for deras framstellning samt cytostatisk, analgetisk och/eller hypotensiv komposition innehallande nemnda acetaler - Google Patents

Cykliska acetaler, forfarande for deras framstellning samt cytostatisk, analgetisk och/eller hypotensiv komposition innehallande nemnda acetaler

Info

Publication number
SE445643B
SE445643B SE7905330A SE7905330A SE445643B SE 445643 B SE445643 B SE 445643B SE 7905330 A SE7905330 A SE 7905330A SE 7905330 A SE7905330 A SE 7905330A SE 445643 B SE445643 B SE 445643B
Authority
SE
Sweden
Prior art keywords
day
acetals
methylglyoxal
product
ascorbic acid
Prior art date
Application number
SE7905330A
Other languages
English (en)
Swedish (sv)
Other versions
SE7905330L (sv
Inventor
A Szent-Gyorgyi
G B Fodor
Original Assignee
Cancer Res Nat Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Nat Found filed Critical Cancer Res Nat Found
Publication of SE7905330L publication Critical patent/SE7905330L/xx
Publication of SE445643B publication Critical patent/SE445643B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7905330A 1978-06-20 1979-06-18 Cykliska acetaler, forfarande for deras framstellning samt cytostatisk, analgetisk och/eller hypotensiv komposition innehallande nemnda acetaler SE445643B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91732778A 1978-06-20 1978-06-20

Publications (2)

Publication Number Publication Date
SE7905330L SE7905330L (sv) 1979-12-21
SE445643B true SE445643B (sv) 1986-07-07

Family

ID=25438634

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7905330A SE445643B (sv) 1978-06-20 1979-06-18 Cykliska acetaler, forfarande for deras framstellning samt cytostatisk, analgetisk och/eller hypotensiv komposition innehallande nemnda acetaler

Country Status (14)

Country Link
JP (1) JPS5513274A (de)
AU (1) AU521500B2 (de)
CA (1) CA1142948A (de)
CH (1) CH641454A5 (de)
DE (1) DE2924077A1 (de)
DK (1) DK160828C (de)
FR (1) FR2429214A1 (de)
GB (1) GB2028309B (de)
HU (1) HU177875B (de)
IE (1) IE48434B1 (de)
IT (1) IT1121294B (de)
NL (1) NL7904249A (de)
NO (1) NO154966C (de)
SE (1) SE445643B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238500A (en) * 1979-04-06 1980-12-09 National Foundation For Cancer Research Cyclic double hemiacetals of enediol compounds and compositions and methods for preparing and using same
JPS57501581A (de) * 1980-08-14 1982-09-02
TWI386448B (zh) 2007-01-26 2013-02-21 Rohm & Haas 光散射組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2108649C3 (de) * 1971-02-24 1978-12-07 Basf Ag, 6700 Ludwigshafen 2-Methyl-2-hepten-6-on-l-al und seine Acetale
DE2232498A1 (de) * 1972-07-01 1974-01-10 Basf Ag Verfahren zur herstellung von benzilmonoketalen
DE2514001A1 (de) * 1975-03-29 1976-10-07 Basf Ag Verfahren zur herstellung von glyoxalmonoacetalen

Also Published As

Publication number Publication date
CH641454A5 (de) 1984-02-29
JPS6410515B2 (de) 1989-02-22
NO792040L (no) 1979-12-21
JPS5513274A (en) 1980-01-30
GB2028309B (en) 1982-08-04
AU4768979A (en) 1980-01-03
SE7905330L (sv) 1979-12-21
CA1142948A (en) 1983-03-15
DK256679A (da) 1979-12-21
GB2028309A (en) 1980-03-05
FR2429214B1 (de) 1985-03-08
FR2429214A1 (fr) 1980-01-18
DE2924077A1 (de) 1980-01-17
DK160828C (da) 1991-10-14
IT1121294B (it) 1986-04-02
HU177875B (en) 1982-01-28
DK160828B (da) 1991-04-22
IT7923721A0 (it) 1979-06-20
AU521500B2 (en) 1982-04-08
IE48434B1 (en) 1985-01-23
DE2924077C2 (de) 1990-08-16
NL7904249A (nl) 1979-12-27
NO154966C (no) 1987-01-21
NO154966B (no) 1986-10-13

Similar Documents

Publication Publication Date Title
CN110938032A (zh) 有机硒化合物及其用途
KR20010051662A (ko) 암을 포함한 악성 신생물에 사용하는 항악성종양제
SE445643B (sv) Cykliska acetaler, forfarande for deras framstellning samt cytostatisk, analgetisk och/eller hypotensiv komposition innehallande nemnda acetaler
US4287205A (en) Hypotensive and analgesic compounds and compositions and methods for using same
Hattori et al. Post-operative long-term adjuvant immunochemotherapy with mitomycin-C, PSK and FT-207 in gastric cancer patients
CN100582101C (zh) 抗肿瘤剂
CN110938033A (zh) 硒氰化合物及其用途
JP2000302762A (ja) 放射線および化学療法における感受性増強剤であるグリシジアゾール金属塩、並びにそれらの製造方法および使用
CN110423254B (zh) 一种具有不对称单取代香豆素四价铂结构化合物、制备方法及其在制备抗肿瘤药物中的应用
CN110575450B (zh) 2,5-呋喃二甲醇在制备抗肿瘤药物中的应用
CN103054802A (zh) 介入治疗肝癌的前阳离子/阳离子脂质体姜黄素制剂及其制备方法
CN105030798B (zh) 一种抗肿瘤的药物组合物及其制备方法和应用
Barry et al. Anticancer Agents: I. Structure-Activity Relationships in a Series of Oxypolysaccharide-Thiosemicarbazide Derivatives
CN1823787A (zh) 灵芝酸在制备癌转移抑制剂中的应用
CN110038009A (zh) 卡格列净在制备抗肿瘤药物中的应用
US11744818B2 (en) Application of trans-1,3-dilinolein in the preparation of medicaments for treating gastric cancer, stomachic tonic, health products and foods
KR100398289B1 (ko) 신규 안트라사이클린 유도체 및 그 제조방법
CN101619084A (zh) 含蒽环类细胞毒素前体药物的制备方法及其应用
CN115505022A (zh) 一种生物碱苷及其应用
CN102516234B (zh) 色氨酸葡萄糖美拉德反应产物，及其制备方法和应用
CN111568890A (zh) 绿原酸、同分异构体或药学上可接受的盐在制备肿瘤化疗增敏药物中的应用
CN112494650A (zh) 一种血卟啉衍生物联合化学药物在肝癌治疗中的应用
CN119326763A (zh) 7H-吲哚[2,3-j]菲啶-7,13(8H)-二酮用作JAK2抑制剂以及用于制备缓解、治疗胰腺癌的药物中的应用
CN119119164A (zh) 一种甘草次酸脲衍生物及其制备方法与用途
CN119039265A (zh) 一种甲基哌嗪-查尔酮类衍生物及其制备方法和应用以及药物制剂

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7905330-2

Effective date: 19940110

Format of ref document f/p: F